BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24136149)

  • 1. Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value.
    Evert M; Frau M; Tomasi ML; Latte G; Simile MM; Seddaiu MA; Zimmermann A; Ladu S; Staniscia T; Brozzetti S; Solinas G; Dombrowski F; Feo F; Pascale RM; Calvisi DF
    Br J Cancer; 2013 Nov; 109(10):2654-64. PubMed ID: 24136149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
    Frau M; Feo F; Pascale RM
    J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA-PKcs: A promising therapeutic target in human hepatocellular carcinoma?
    Pascale RM; Joseph C; Latte G; Evert M; Feo F; Calvisi DF
    DNA Repair (Amst); 2016 Nov; 47():12-20. PubMed ID: 27789167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor DNA-dependent protein kinase catalytic subunit expression is associated with hepatitis B surface antigen status and tumor progression in patients with hepatocellular carcinoma.
    Shimizu T; Aoki T; Mori S; Iso Y; Kato M; Ishizuka M; Kubota K
    Sci Rep; 2018 Oct; 8(1):15019. PubMed ID: 30301934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of heat shock factor 1 transcription activity is associated with hepatocellular carcinoma progression.
    Li S; Ma W; Fei T; Lou Q; Zhang Y; Cui X; Qin X; Zhang J; Liu G; Dong Z; Ma Y; Song Z; Hu Y
    Mol Med Rep; 2014 Nov; 10(5):2313-21. PubMed ID: 25199534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth.
    Xu L; Feng X; Hao X; Wang P; Zhang Y; Zheng X; Li L; Ren S; Zhang M; Xu M
    J Exp Clin Cancer Res; 2019 Feb; 38(1):98. PubMed ID: 30795787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KU-0060648 inhibits hepatocellular carcinoma cells through DNA-PKcs-dependent and DNA-PKcs-independent mechanisms.
    Chen MB; Zhou ZT; Yang L; Wei MX; Tang M; Ruan TY; Xu JY; Zhou XZ; Chen G; Lu PH
    Oncotarget; 2016 Mar; 7(13):17047-59. PubMed ID: 26933997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-PK-A candidate driver of hepatocarcinogenesis and tissue biomarker that predicts response to treatment and survival.
    Cornell L; Munck JM; Alsinet C; Villanueva A; Ogle L; Willoughby CE; Televantou D; Thomas HD; Jackson J; Burt AD; Newell D; Rose J; Manas DM; Shapiro GI; Curtin NJ; Reeves HL
    Clin Cancer Res; 2015 Feb; 21(4):925-33. PubMed ID: 25480831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsp90 Inhibitor STA9090 Sensitizes Hepatocellular Carcinoma to Hyperthermia-Induced DNA Damage by Suppressing DNA-PKcs Protein Stability and mRNA Transcription.
    Liu L; Deng Y; Zheng Z; Deng Z; Zhang J; Li J; Liang M; Zhou X; Tan W; Yang H; Neckers LM; Zou F; Chen X
    Mol Cancer Ther; 2021 Oct; 20(10):1880-1892. PubMed ID: 34376581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3.
    Zhang J; Huang JZ; Zhang YQ; Zhang X; Zhao LY; Li CG; Zhou YF; Wei H; Yu J
    EBioMedicine; 2020 Mar; 53():102701. PubMed ID: 32151798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
    Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
    Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRG1 promotes hepatocarcinogenesis by regulating proliferation and invasiveness.
    Kaufmann B; Wang B; Zhong S; Laschinger M; Patil P; Lu M; Assfalg V; Cheng Z; Friess H; Hüser N; von Figura G; Hartmann D
    PLoS One; 2017; 12(7):e0180225. PubMed ID: 28700662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of DNA-PKcs as a primary resistance factor of TIC10 in hepatocellular carcinoma cells.
    Cheng L; Liu YY; Lu PH; Peng Y; Yuan Q; Gu XS; Jin Y; Chen MB; Bai XM
    Oncotarget; 2017 Apr; 8(17):28385-28394. PubMed ID: 28415690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis.
    Marquard S; Thomann S; Weiler SME; Bissinger M; Lutz T; Sticht C; Tóth M; de la Torre C; Gretz N; Straub BK; Marquardt J; Schirmacher P; Breuhahn K
    Cell Commun Signal; 2020 Oct; 18(1):166. PubMed ID: 33097058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
    Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
    Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
    World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
    Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
    BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.